Frontlight ResearchEarly access
Active, not recruitingPhase 4
the PHENOSAR Trial: Use of Antibiotics in Treatment of Sarcoidosis
Key facts
- Who runs it
- St. Antonius Hospital
- Where
- Netherlands1 site in 1 countryChoose a country to see its sites
- Status
- Active, not recruiting
- Phase
- Phase 4
- People taking part
- 40 people, planned
- Started
- 15 Feb 2023
- Expected to end
- 1 Dec 2026
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- FDG-PET/CT
- Record updated
- 12 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Biopsy proven sarcoidosis
- No treatment indication for the sarcoidosis
- Inflammatory activity according to FDG-PET scan at baseline
- SUVmax above 3 in the lung and/or above 5 in mediastinum/hili
Who cannot take part
- Increased duration of QT interval (>440ms for men and >450ms for women) on ECG
- Hearing deficits, as this is a possible side effect of azithromycin
- Being pregnant or breastfeeding at time of inclusion
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In this study it is investigated whether treatment with azithromycin in combination with doxycycline reduces the bacterial load of C. acnes in granulomatous tissue of patients with sarcoidosis and subsequently decreases the inflammatory activation measured by FDG uptake and serum biomarkers.
The 4 groups in the trial
- C Acnes present in granulomatous tissue, treatment with antibioticsExisting treatment, for comparison
patients who are in this arm will receive azithromycin and doxycycline for 3 months
Treatment: FDG-PET/CT
- C Acnes present in granulomatous tissue, treatment with placeboPlacebo, for comparison
patients who are in this arm will receive placebo for 3 months
Treatment: FDG-PET/CT
- C Acnes NOT present in granulomatous tissue, treatment with antibioticsExisting treatment, for comparison
patients who are in this arm will receive azithromycin and doxycycline for 3 months
Treatment: FDG-PET/CT
- C. Acnes NOT present in granulomatous tissue, treatment with placeboPlacebo, for comparison
patients who are in this arm will receive placebo for 3 months
Treatment: FDG-PET/CT
Data and sources
- Registry record
- Listed on ClinicalTrials.gov and on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Official title
- PHENOtype Based Therapy With Antibiotics in SARcoidosis Patients With and Without Presence of Cutibacterium Acnes in Granulomatous Tissue
- Record updated
- 12 February 2026